Literature DB >> 11167997

Haemodialysis monocytopenia: differential sequestration kinetics of CD14+CD16+ and CD14++ blood monocyte subsets.

W A Nockher1, J Wiemer, J E Scherberich.   

Abstract

In peripheral blood the majority of circulating monocytes present a CD14highCD16- (CD14++) phenotype, while a subpopulation shows a CD14lowCD16+ (CD14+CD16+) surface expression. During haemodialysis (HD) using cellulosic membranes transient leukopenia occurs. In contrast, synthetic biocompatible membranes do not induce this effect. We compared the sequestration kinetics for the CD14+CD16+ and CD14++ monocyte subsets during haemodialysis using biocompatible dialysers. Significant monocytopenia, as measured by the leucocyte count, occurred only during the first 30 min. However, remarkable differences were observed between the different monocyte subsets. CD14++ monocyte numbers dropped to 77 +/- 13% of the predialysis level after 15 min, increasing to > or = 93% after 60 min. In contrast, the CD14+CD16+ subset decreased to 33 +/- 15% at 30 min and remained suppressed for the course of dialysis (67 +/- 11% at 240 min). Approximately 6 h after the end of HD the CD14+CD16+ cells returned to basal levels. Interestingly, the CD14+CD16+ monocytes did not show rebound monocytosis while a slight monocytosis of CD14++ monocytes was occasionally observed during HD. A decline in CD11c surface density paralleled the sequestration of CD14+CD16+ monocytes. Basal surface densities of important adhesion receptors differed significantly between the CD14+CD16+ and CD14++ subsets. In conclusion, during HD the CD14+CD16+ subset revealed different sequestration kinetics, with a more pronounced and longer disappearance from the blood circulation, compared with CD14++ monocytes. This sequestration kinetics may be due to a distinct surface expression of major adhesion receptors which facilitate leucocyte-leucocyte, as well as leucocyte-endothelial, interactions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11167997      PMCID: PMC1905970          DOI: 10.1046/j.1365-2249.2001.01436.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

Review 1.  Blood monocyte phenotypes and soluble endotoxin receptor CD14 in systemic inflammatory diseases and patients with chronic renal failure.

Authors:  J E Scherberich; W A Nockher
Journal:  Nephrol Dial Transplant       Date:  2000-05       Impact factor: 5.992

Review 2.  CD14++ monocytes, CD14+/CD16+ subset and soluble CD14 as biological markers of inflammatory systemic diseases and monitoring immunosuppressive therapy.

Authors:  J E Scherberich; W A Nockher
Journal:  Clin Chem Lab Med       Date:  1999-03       Impact factor: 3.694

3.  Clinical implications of hemodialysis membrane biocompatibility.

Authors:  R M Hakim
Journal:  Kidney Int       Date:  1993-09       Impact factor: 10.612

Review 4.  Long-term dialysis and cellular immunity: a critical survey.

Authors:  B Descamps-Latscha; A Herbelin
Journal:  Kidney Int Suppl       Date:  1993-06       Impact factor: 10.545

Review 5.  Immunological considerations of the uremic and dialyzed patient.

Authors:  L Chatenoud; P Jungers; B Descamps-Latscha
Journal:  Kidney Int Suppl       Date:  1994-01       Impact factor: 10.545

6.  Selective mobilization of CD14(+)CD16(+) monocytes by exercise.

Authors:  B Steppich; F Dayyani; R Gruber; R Lorenz; M Mack; H W Ziegler-Heitbrock
Journal:  Am J Physiol Cell Physiol       Date:  2000-09       Impact factor: 4.249

7.  The novel subset of CD14+/CD16+ blood monocytes exhibits features of tissue macrophages.

Authors:  H W Ziegler-Heitbrock; G Fingerle; M Ströbel; W Schraut; F Stelter; C Schütt; B Passlick; A Pforte
Journal:  Eur J Immunol       Date:  1993-09       Impact factor: 5.532

8.  The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients.

Authors:  G Fingerle; A Pforte; B Passlick; M Blumenstein; M Ströbel; H W Ziegler-Heitbrock
Journal:  Blood       Date:  1993-11-15       Impact factor: 22.113

9.  Granulocyte activation and adhesion molecules during hemodialysis with cuprophane and a high-flux biocompatible membrane.

Authors:  C Combe; M Pourtein; V de Précigout; A Baquey; D Morel; L Potaux; P Vincendeau; J H Bézian; M Aparicio
Journal:  Am J Kidney Dis       Date:  1994-09       Impact factor: 8.860

10.  Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients.

Authors:  W A Nockher; L Bergmann; J E Scherberich
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

View more
  9 in total

1.  Properties of human blood monocytes. I. CD91 expression and log orthogonal light scatter provide a robust method to identify monocytes that is more accurate than CD14 expression.

Authors:  Dorothy Hudig; Kenneth W Hunter; W John Diamond; Doug Redelman
Journal:  Cytometry B Clin Cytom       Date:  2013-10-08       Impact factor: 3.058

Review 2.  Monocyte subpopulations and cardiovascular risk in chronic kidney disease.

Authors:  Gunnar H Heine; Alberto Ortiz; Ziad A Massy; Bengt Lindholm; Andrzej Wiecek; Alberto Martínez-Castelao; Adrian Covic; David Goldsmith; Gültekin Süleymanlar; Gérard M London; Gianfranco Parati; Rosa Sicari; Carmine Zoccali; Danilo Fliser
Journal:  Nat Rev Nephrol       Date:  2012-03-13       Impact factor: 28.314

3.  Properties of human blood monocytes. II. Monocytes from healthy adults are highly heterogeneous within and among individuals.

Authors:  Dorothy Hudig; Kenneth W Hunter; W John Diamond; Doug Redelman
Journal:  Cytometry B Clin Cytom       Date:  2013-12-10       Impact factor: 3.058

4.  Rapid and quantitative detection of p38 kinase pathway in mouse blood monocyte.

Authors:  Jingyong Zhao; Glenn Evans; Weiming Li; Lisa Green; Shaoyou Chu; Phil Marder; Songqing Na
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-04-09       Impact factor: 2.416

5.  Application of FTIR-ATR Spectroscopy to Determine the Extent of Lipid Peroxidation in Plasma during Haemodialysis.

Authors:  Adam Oleszko; Sylwia Olsztyńska-Janus; Tomasz Walski; Karolina Grzeszczuk-Kuć; Jolanta Bujok; Katarzyna Gałecka; Albert Czerski; Wojciech Witkiewicz; Małgorzata Komorowska
Journal:  Biomed Res Int       Date:  2015-04-19       Impact factor: 3.411

Review 6.  Monocytes in Uremia.

Authors:  Matthias Girndt; Bogusz Trojanowicz; Christof Ulrich
Journal:  Toxins (Basel)       Date:  2020-05-21       Impact factor: 4.546

Review 7.  Immune System Dysfunction and Inflammation in Hemodialysis Patients: Two Sides of the Same Coin.

Authors:  Susanna Campo; Antonio Lacquaniti; Domenico Trombetta; Antonella Smeriglio; Paolo Monardo
Journal:  J Clin Med       Date:  2022-06-28       Impact factor: 4.964

Review 8.  Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions.

Authors:  Giorgio Ghigliotti; Chiara Barisione; Silvano Garibaldi; Patrizia Fabbi; Claudio Brunelli; Paolo Spallarossa; Paola Altieri; Gianmarco Rosa; Giovanni Spinella; Domenico Palombo; Razvan Arsenescu; Violeta Arsenescu
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

9.  Hemodialysis-related changes in phenotypical features of monocytes.

Authors:  Vassilios Liakopoulos; Andreas Jeron; Aneri Shah; Dunja Bruder; Peter R Mertens; Xenia Gorny
Journal:  Sci Rep       Date:  2018-09-18       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.